OM:BIOA BBiotechs
BioArctic AB (publ)'s (STO:BIOA B) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
BioArctic (STO:BIOA B) has had a rough month with its share price down 14%. But if you pay close attention, you might...
OM:PROBBiotechs
Probi AB (publ) (STO:PROB) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Probi's (STO:PROB) stock is up by a considerable 13% over the past three months. But the company's key financial...
OM:SOBIBiotechs
Swedish Orphan Biovitrum AB (publ) (STO:SOBI) is a favorite amongst institutional investors who own 38%
Key Insights Institutions' substantial holdings in Swedish Orphan Biovitrum implies that they have significant...
OM:HNSABiotechs
Does Hansa Biopharma (STO:HNSA) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
OM:DMYD BBiotechs
We Think Diamyd Medical (STO:DMYD B) Needs To Drive Business Growth Carefully
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
OM:VICOBiotechs
We Think Vicore Pharma Holding (STO:VICO) Needs To Drive Business Growth Carefully
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
OM:VITRBiotechs
Should Weakness in Vitrolife AB (publ)'s (STO:VITR) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Vitrolife (STO:VITR) has had a rough three months with its share price down 34%. However, the company's fundamentals...
OM:GUARDBiotechs
Here's Why Guard Therapeutics International (STO:GUARD) Must Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, although...
OM:IMMUBiotechs
Market Sentiment Around Loss-Making Mendus AB (publ) (STO:IMMU)
Mendus AB (publ) ( STO:IMMU ) is possibly approaching a major achievement in its business, so we would like to shine...
OM:BIOG BBiotechs
Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)
Key Insights The projected fair value for BioGaia is kr95.22 based on 2 Stage Free Cash Flow to Equity BioGaia's...
OM:XSPRAYBiotechs
Xspray Pharma's Recent Gains Improve Losses On Insider Purchases Worth kr6.5m
Insiders who bought kr6.5m worth of Xspray Pharma AB (publ) ( STO:XSPRAY ) stock in the last year recovered part of...
OM:BIOVIC BBiotechs
Biovica International AB (publ) (STO:BIOVIC B): Are Analysts Optimistic?
Biovica International AB (publ) ( STO:BIOVIC B ) is possibly approaching a major achievement in its business, so we...
OM:EGTXBiotechs
Insider Buyers Lose kr254k As Egetis Therapeutics Sheds kr125m
The recent 11% drop in Egetis Therapeutics AB (publ)'s ( STO:EGTX ) stock could come as a blow to insiders who...
OM:BINVBiotechs
Bernd Seizinger Bought 120% More Shares In BioInvent International
Even if it's not a huge purchase, we think it was good to see that Bernd Seizinger, the Independent Director of...
OM:DVYSRBiotechs
Independent Director of Devyser Diagnostics Fredrik Dahl Buys 78% More Shares
Even if it's not a huge purchase, we think it was good to see that Fredrik Dahl, the Independent Director of Devyser...
NGM:APTABiotechs
Aptahem Reports Second Quarter 2023 Earnings
Aptahem ( NGM:APTA ) Second Quarter 2023 Results Key Financial Results Net loss: kr2.74m (loss widened by 53% from 2Q...
OM:CYXOBiotechs
When Will Cyxone AB (publ) (STO:CYXO) Become Profitable?
We feel now is a pretty good time to analyse Cyxone AB (publ)'s ( STO:CYXO ) business as it appears the company may be...
OM:CRNO BBiotechs
Will Cereno Scientific (STO:CRNO B) Spend Its Cash Wisely?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
OM:BINVBiotechs
Companies Like BioInvent International (STO:BINV) Are In A Position To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
OM:DVYSRBiotechs
These Analysts Just Made An Incredible Downgrade To Their Devyser Diagnostics AB (publ) (STO:DVYSR) EPS Forecasts
Today is shaping up negative for Devyser Diagnostics AB (publ) ( STO:DVYSR ) shareholders, with the analysts delivering...
OM:VITRBiotechs
An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Vitrolife fair value estimate is kr202 Current share price of...
OM:ABLIBiotechs
Here's Why We're A Bit Worried About Abliva's (STO:ABLI) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
OM:CANTABiotechs
Analysts Expect Breakeven For Cantargia AB (publ) (STO:CANTA) Before Long
With the business potentially at an important milestone, we thought we'd take a closer look at Cantargia AB (publ)'s...
OM:SOBIBiotechs
Possible Bearish Signals With Swedish Orphan Biovitrum Insiders Disposing Stock
Over the past year, many Swedish Orphan Biovitrum AB (publ) ( STO:SOBI ) insiders sold a significant stake in the...